Advertisement
Screener

Denali Therapeutics Inc. (DNLI) Market Cap

Denali Therapeutics Inc. (DNLI) Market Cap

  • 2026-09-03: Market Cap $3.64B.
  • 2026-07-31: Market Cap $3.68B.
  • 2026-06-30: Market Cap $4.11B.
  • 2026-05-01: Market Cap $2.9B.

Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.

Available history
2017-12-31 to 2026-09-03
Data captured

Historical Market Cap

DateMarket Cap
2026-09-03$3.64B
2026-07-31$3.68B
2026-06-30$4.11B
2026-05-01$2.9B
2026-03-31$3.05B
2026-02-20$3.2B
2025-12-31$2.58B
2025-10-31$2.39B
2025-09-30$2.13B
2025-08-05$2.09B
2025-06-30$2.04B
2025-04-30$2.42B
2025-03-31$1.97B
2025-02-21$3.01B
2024-12-31$2.94B
2024-10-30$3.86B
2024-09-30$4.19B
2024-07-25$3.45B
2024-06-30$3.32B
2024-04-30$2.2B
2024-03-31$2.92B
2024-02-20$2.3B
2023-12-31$2.97B
2023-10-30$2.54B
2023-09-30$2.85B
2023-07-31$3.91B
2023-06-30$4.05B
2023-05-01$3.53B
2023-03-31$3.15B
2023-02-21$3.93B
2022-12-31$3.78B
2022-10-27$3.77B
2022-09-30$3.8B
2022-08-01$4.04B
2022-06-30$3.62B
2022-04-28$3.08B
2022-03-31$3.95B
2022-02-18$4B
2021-12-31$5.45B
2021-10-29$5.9B
2021-09-30$6.16B
2021-07-28$6.27B
2021-06-30$9.53B
2021-04-26$7.29B
2021-03-31$6.92B
2021-02-17$7.6B
2020-12-31$10.1B
2020-10-28$5.53B
2020-09-30$4.29B
2020-08-03$2.57B
2020-06-30$2.56B
2020-04-29$2.45B
2020-03-31$1.85B
2020-02-19$2.76B
2019-12-31$1.68B
2019-10-30$1.5B
2019-09-30$1.47B
2019-07-31$2.05B
2019-06-30$1.99B
2019-05-01$2.27B
2019-03-31$2.21B
2019-03-05$2.07B
2018-12-31$1.96B
2018-11-02$1.61B
2018-09-30$2.04B
2018-08-02$1.33B
2018-06-30$1.42B
2018-05-04$1.79B
2018-03-31$1.82B
2017-12-31$1.37B

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tarsus Pharmaceuticals, Inc. (TARS)United States$3.329B-58.60
Relay Therapeutics, Inc. (RLAY)United States$3.884B-14.30
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
Greenland Mines Ltd (GRML)United States$2.362B
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Adaptive Biotechnologies Corp (ADPT)United States$4.719B-53.43